KalVista Pharmaceuticals, Inc. (KALV) earnings
KALV earnings moved a median of -1.61% by the close. Quarterly and annual KALV reports and results, each read against the price at its own news timestamp. Back to the KALV overview →
10 measured KALV earnings events.
Where these KALV earnings landedvs 10 measured KALV earnings reactions
| Middle 50% of KALV earnings reactions | -5.29% to +0.48% |
|---|---|
| Median reaction (to close) | -1.61% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 KALV earnings events with a measured close landed between -5.29% and +0.48%; 30% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q KalVista Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.19% | |
| Form 10-Q KalVista Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -5.36% | +0.70% | |
| Form 10-Q KalVista Pharmaceuticals For: Jul 31 | SEC filing · Form 10-Q | -4.58% | -12.83% | |
| Form 10-K KalVista Pharmaceuticals For: Apr 30 | SEC filing · Form 10-K | -2.52% | -2.42% | |
| Form 10-Q KalVista Pharmaceuticals For: Jan 31 | SEC filing · Form 10-Q | -0.43% | -0.81% | |
| Form 10-Q KalVista Pharmaceuticals For: Oct 31 | SEC filing · Form 10-Q | +2.56% | +9.00% | |
| Form 10-Q KalVista Pharmaceuticals For: Jul 31 | SEC filing · Form 10-Q | -0.53% | -6.09% | |
| Form 10-K KalVista Pharmaceuticals For: Apr 30 | SEC filing · Form 10-K | -0.71% | +3.25% | |
| Form 10-Q KalVista Pharmaceuticals For: Jan 31 | SEC filing · Form 10-Q | +0.47% | -2.88% | |
| Form 10-Q KalVista Pharmaceuticals For: Oct 31 | SEC filing · Form 10-Q | -3.31% | -8.31% |
Keep exploring
More KALV: analyst actions → · SEC filings → · KALV overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EyePoint, Inc. (EYPT) | 439 | -0.25% | 46% |
| Abeona Therapeutics Inc. (ABEO) | 438 | +0.09% | 51% |
| Zymeworks Inc. (ZYME) | 438 | 0.00% | 50% |
| Exact Sciences Corporation (EXAS) | 437 | +0.08% | 56% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.